Thrombocytopenia associated with c7E3 Fab (abciximab).

Schell, D A; Ganti, A K; Levitt, R; Potti, A

Schell, D A; Ganti, A K; Levitt, R; Potti, A.

Affiliation

Schell DA; Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, 1919 N Elm Street, Fargo, ND 58102, USA.

Ann Hematol ; 81(2): 76-9, 2002 Feb.

Article in En | MEDLINE | ID: mdl-11907786

Subject(s)

Antibodies, Monoclonal/adverse effects; Immunoglobulin Fab Fragments/adverse effects; Platelet Aggregation Inhibitors/adverse effects; Thrombocytopenia/chemically induced; Abciximab; Adult; Aged; Antibodies, Monoclonal/therapeutic use; Coronary Disease/drug therapy; Female; Humans; Immunoglobulin Fab Fragments/therapeutic use; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Thrombocytopenia/physiopathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Antibodies, Monoclonal Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Year: 2002 Document type: Article

Search on Google

XML

PubMed Links